2024 annual financial data
NovoCure 2024 Operating margin
Direct answer
Operating margin was -28.17%.
Operating income was -170,496,000 USD and net income was -168,627,000 USD.
Operating cash flow was -26,369,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 605,220,000 USD
- Operating income
- -170,496,000 USD
- Net income
- -168,627,000 USD
- Operating cash flow
- -26,369,000 USD